Gennova Biopharmaceuticals Ltd
- All
- News
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Envoys From 100 Countries To Visit Pune On December 4 Amid Vaccine Production
Ambassadors and envoys from 100 countries will visit Serum Institute of India and Gennova Biopharmaceuticals Ltd in Pune on December 4 amid the coronavirus outbreak and race for vaccines to combat the infection, a senior official said on Tuesday.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Envoys From 100 Countries To Visit Pune On December 4 Amid Vaccine Production
Ambassadors and envoys from 100 countries will visit Serum Institute of India and Gennova Biopharmaceuticals Ltd in Pune on December 4 amid the coronavirus outbreak and race for vaccines to combat the infection, a senior official said on Tuesday.
